Table 2. The trend of FSH, AMH, and E2 hormone serum levels over the one-month treatment period with very small stem cells from peripheral blood in patients with premature ovarian failure.
Type of hormone Pre-treatment 2nd month 4th month p-value
FSH mIU/mL, Mean (SD) 45.0 (12.1) 44.3 (17.4) 33.2 (12.4) <0.001
AMH ng/mL, Mean (SD) 0.1 (0.1) 0.13 (0.1) 0.15 (0.1) <0.001
E2 pg/mL, Mean (SD) 85.7 (23.6) 81.2 (22.7) 77.2 (25.6) 0.001

*Data were provided as mean and standard deviation.